Form 4: PetMed Express CEO Sandra Campos Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Sandra Campos, CEO and President of PetMed Express, reports acquisition of restricted stock units.

Summary

  • Sandra Campos, CEO and President of PetMed Express, filed a Form 4 on May 01, 2024, reporting transactions related to PetMed Express Inc. [PETS].
  • On April 29, 2024, Campos acquired 1,623 shares of Common Stock and 483,092 Restricted Stock Units (RSUs) at a price of $0.
  • Following the reported transactions, Campos beneficially owns 490,592 shares of Common Stock.
  • The RSUs vest in three equal installments on the first, second, and third anniversaries of April 29, 2024, contingent upon continued employment with the company.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Positives

  • The acquisition of RSUs by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of RSUs is contingent upon continued employment with the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders.

Stakeholder Impact

  • The reported transactions provide transparency to shareholders regarding the CEO's stake in the company.

Key Dates

DateDescription
04/29/2024Date of stock and RSU acquisition
04/29/2024Vesting start date for Restricted Stock Units
05/01/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.